Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129026) titled 'Efficacy Observation and Related Research of Upadacitinib Combined with Biologic Agents in the Treatment of Patients with Crohn's Disease' on July 29.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Northern Jiangsu People's Hospital
Condition:
Crohn
Intervention:
UPA group:UPA
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2025-10-20
Target Sample Size: UPA group:30;UPA+UST group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=297184
Published by HT Digital Content Services with permission from H...